INS and diabetes mellitus: We previously reported that proinsulin/alum immunization had little ability to induce diabetes remission in newly diabetic NOD mice [40] and that data were reproduced in Figure 1F. Here, we observed that 2/3 of the newly diabetic mice receiving the combined therapy became normoglycemic and remained normoglycemic for at least 5 weeks.